Next earnings date: 27 Oct 2025
Cipla Limited – NSE:CIPLA.NS
Cipla Limited stock price today
Cipla Limited stock price monthly change
Cipla Limited stock price quarterly change
Cipla Limited stock price yearly change
Cipla Limited key metrics
Market Cap | 1.19T |
Enterprise value | 1.21T |
P/E | 27.18 |
EV/Sales | 4.59 |
EV/EBITDA | 17.10 |
Price/Sales | 4.60 |
Price/Book | 4.28 |
PEG ratio | -3.32 |
EPS | 51.05 |
Revenue | 255.27B |
EBITDA | 67.88B |
Income | 41.21B |
Revenue Q/Q | 8.77% |
Revenue Y/Y | 124.00% |
Profit margin | 16.94% |
Oper. margin | 21.99% |
Gross margin | 50.64% |
EBIT margin | 21.99% |
EBITDA margin | 26.59% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCipla Limited stock price history
Cipla Limited stock forecast
Cipla Limited financial statements
| Jun 2023 | 62.69B | 9.95B | 15.88% |
|---|---|---|---|
| Sep 2023 | 65.89B | 11.30B | 17.16% |
| Dec 2023 | 65.05B | 10.55B | 16.23% |
| Mar 2024 | 61.63B | 9.39B | 15.24% |
| 2026 | 306.76B | 52.00B | 16.95% |
|---|---|---|---|
| 2027 | 325.22B | 51.42B | 15.81% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-29 | 14.95 | 16.12 |
|---|
| Payout ratio | 0% |
|---|
| 2016 | 0.39% |
|---|---|
| 2017 | 0.34% |
| 2019 | 0.57% |
| 2020 | 1.95% |
| 2022 | 0.49% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 313770900000 | 62.81B | 20.02% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 327178200000 | 59.15B | 18.08% |
| Jun 2023 | 4.78B | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 5.80B | 0 | 0 |
| Dec 2023 | 4.66B | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Cipla Limited alternative data
| Aug 2023 | 25,927 |
|---|---|
| Sep 2023 | 32,323 |
| Oct 2023 | 32,323 |
| Nov 2023 | 32,323 |
| Dec 2023 | 32,323 |
| Jan 2024 | 32,323 |
| Feb 2024 | 32,323 |
| Mar 2024 | 32,323 |
| Apr 2024 | 32,323 |
| May 2024 | 32,323 |
| Jun 2024 | 32,323 |
| Jul 2024 | 32,323 |
Cipla Limited other data
| Insider | Compensation |
|---|---|
Mr. Umang Vohra (1971) MD, Global Chief Executive Officer & Executive Director | $181,300,000 |
Ms. Samina Hamied (1976) Executive Vice-Chairperson | $81,500,000 |
-
What's the price of Cipla Limited stock today?
One share of Cipla Limited stock can currently be purchased for approximately $930.5.
-
When is Cipla Limited's next earnings date?
Cipla Limited is estimated to report earnings on Monday, 27 Oct 2025.
-
Does Cipla Limited pay dividends?
Yes, Cipla Limited pays dividends and its trailing 12-month yield is 0.86% with 0% payout ratio. The last Cipla Limited stock dividend of $0 was paid on 12 Sep 2025.
-
How much money does Cipla Limited make?
Cipla Limited has a market capitalization of 1.19T and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.14% to 257.74B US dollars. Cipla Limited earned 41.22B US dollars in net income (profit) last year or $16.12 on an earnings per share basis.
-
What is Cipla Limited's stock symbol?
Cipla Limited is traded on the NSE under the ticker symbol "CIPLA.NS".
-
What is Cipla Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Cipla Limited?
Shares of Cipla Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cipla Limited's key executives?
Cipla Limited's management team includes the following people:
- Mr. Umang Vohra MD, Global Chief Executive Officer & Executive Director(age: 54, pay: $181,300,000)
- Ms. Samina Hamied Executive Vice-Chairperson(age: 49, pay: $81,500,000)
-
How many employees does Cipla Limited have?
As Jul 2024, Cipla Limited employs 32,323 workers.
-
When Cipla Limited went public?
Cipla Limited is publicly traded company for more then 29 years since IPO on 1 Jan 1996.
-
What is Cipla Limited's official website?
The official website for Cipla Limited is cipla.com.
-
How can i contact Cipla Limited?
Cipla Limited can be reached via phone at +91 22 2482 6000.
Cipla Limited company profile:
Cipla Limited
cipla.comNSE
27,764
Drug Manufacturers - General
Healthcare
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Cipla Limited has a licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; a license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.
Mumbai, 400013
:
ISIN: INE059A01026
CUSIP: Y1R6LH108
